(Q35537898)

8 August 2017

1 reference

title

Statins and their potential targets in multiple sclerosis therapy (English)

1 reference

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

11 March 2024

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

11 March 2024

1

Olaf Stüve

1 reference

8 August 2017

6

Lawrence Steinman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14498824

11 March 2024

author name string

Thomas Prod'homme

2

1 reference

8 August 2017

Anthony Slavin

3

1 reference

8 August 2017

Sawsan Youssef

4

1 reference

8 August 2017

Shannon Dunn

5

1 reference

8 August 2017

Scott S. Zamvil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14498824

11 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14728222.7.5.613

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Expert Opinion on Therapeutic Targets

11 March 2024

published in

1 reference

8 August 2017

7

1 reference

8 August 2017

5

1 reference

8 August 2017

613-622

1 reference

Revised estimate of the prevalence of multiple sclerosis in the united states

8 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Immunological aspects of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Sex differences in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Structural mechanism for statin inhibition of HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Effects of statins on triglyceride metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Myopathy and rhabdomyolysis with lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Statins and risk of polyneuropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Isoprenoids as mediators of the biological effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Prenyl proteins in eukaryotic cells: a new type of membrane anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Rho GTPases and signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Non-lipid-related effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Statins as anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Statins as potential therapeutic agents in neuroinflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

The T lymphocyte in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Regulation of MHC class II genes: lessons from a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Adhesion molecule expression and regulation on cells of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

CD2-mediated adhesion facilitates T lymphocyte antigen recognition function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Exacerbations of multiple sclerosis in patients treated with gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Costimulation: building an immunological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.613

Multiple sclerosis: a two-stage disease

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Relevance of experimental allergic encephalomyelitis to multiple sclerosis

11 March 2024

4

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Epidemiology of multiple sclerosis: a critical overview.

11 March 2024

9

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

11 March 2024

16

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

11 March 2024

21

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

11 March 2024

23

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Drug Metabolism and Disposition

11 March 2024

27

21

567

DAIN JG

1993

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome

11 March 2024

30

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Posttranslational modification of proteins by isoprenoids in mammalian cells

11 March 2024

38

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

11 March 2024

40

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

11 March 2024

46

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

T-lymphocyte entry into the central nervous system

11 March 2024

51

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Statins as a newly recognized type of immunomodulator

11 March 2024

60

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation

11 March 2024

68

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1

11 March 2024

70

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Inhibition of monocyte chemotactic protein-1 synthesis by statins

11 March 2024

71

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Ciba Foundation Symposium

11 March 2024

72

118

102

SPRINGER TA

1986

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

11 March 2024

76

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

The adhesion molecule and cytokine profile of multiple sclerosis lesions

11 March 2024

77

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation

11 March 2024

82

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

11 March 2024

83

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

11 March 2024

87

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

11 March 2024

90

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

11 March 2024

96

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

11 March 2024

97

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.613

11 March 2024

Identifiers

1 reference

8 August 2017

1 reference